University of Minnesota

Program Logo
Name of ProgramUniversity of Minnesota
First Year of APPCN Membership2017
Program AddressDepartment of Pediatrics, 2450 Riverside Ave S.
RPRB 550
Minneapolis, MN 55454
United States
Map It
Director's Name and CredentialsRichard Ziegler, PhD, LP
Director's Email AddressEmail hidden; Javascript is required.
I. Co-Director's Name and CredentialsKelly King, PhD, ABPP-CN, LP
Program's Primary ContactDirector
Primary Emphasis
  • Pediatric
Program Websiteumn.edu
Program Email AddressEmail hidden; Javascript is required.
Does Program Interview Applicants at INS?Yes
Does Program Offer Phone or Video Interviews?Yes
Does Program Offer On-Site Interviews?Yes
Additional Notes About InterviewsIn the context of the COVID-19 pandemic all interviews will be conducted virtually
Application Deadline01/04
Residency Start Date07/31/2021, 08/31/2021; we can be flexible
Clinical Neuropsychology Pediatric Residency Openings For This Cycle2
Clinical Neuropsychology Residents In Program5
Clinical Neuropsychologists Full-Time4
Clinical Neuropsychologists Part-Time1
Clinical Neuropsychologists Full-Time With ABPP1
Graduate Training of Residency Applicants (Preferred)Clinical psychology, neuropsychology, school psychology, counseling psychology
Graduate Training of Residency Applicants (Accepted)Clinical psychology, neuropsychology, school psychology, counseling psychology
Graduate Training of Residency Applicants (Not Accepted)Non-APA/CPA-approved graduate programs or internships
Availability of Patient Populations (Adult, Weak)We do see young adults and adults with neurometabolic diseases
Emphases of Training Opportunities (Pediatric, Strong)Neuropsychological assessment, neuropsychological consultation
Emphases of Training Opportunities (Pediatric, Moderate)Research, supervision of by resident of other trainees, forensics
Emphases of Training Opportunities (Pediatric, Weak)Psychotherapy
Emphases of Training Opportunities (Pediatric, Unavailable)Rehabilitation
Availability of Patient Populations (Pediatric, Strong)Neurodegenerative conditions (adrenoleukodystrophy, mucopolysaccharidoses, gangliosidoses, etc.), prenatal and perinatal conditions, genetic conditions (NF1, Noonan syndrome, 22q11.2 deletion, etc.), international adoption with associated in-utero exposures and trauma, refugee and minority populations, hematological/oncological disorders with associated stem cell transplant (ALL, Fanconi anemia, sickle cell, etc.), neuro-oncological disorders, solid organ transplant, complex neuropsychiatric and neurodevelopmental disorders (e.g. psychosis, schizophrenia, ASD, bipolar, etc.), concussion, other neurological disorders
Availability of Patient Populations (Pediatric, Moderate)Traumatic brain injury (moderate to severe), stroke, uncomplex LD/ADHD, speech/language impairment, in-school consultation, NICU follow-up clinic
Availability of Patient Populations (Pediatric, Weak)Inpatient
Last Updated09/24/2020
Save Entry Download PDF
Scroll to Top